BGP Products Operations

BGP Products Operations is an active Swiss pharmaceutical operating entity within the Viatris group that imports, exports, licenses, markets and distributes pharmaceutical products. The company appears to function primarily as a legal, commercial and brand-owning vehicle for legacy Mylan/Abbott established products and other marketed medicines rather than as a standalone R&D biotech developer. It is associated with a broad portfolio of branded and generic medicines commercialized across multiple therapeutic areas, and has been referenced on product labeling and corporate disclosures in several countries. Following the creation of Viatris from the combination of Mylan and Upjohn in 2020, BGP Products Operations has remained part of the Viatris corporate structure.